These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
3. Cushing's syndrome. Sheeler LR Urol Clin North Am; 1989 Aug; 16(3):447-55. PubMed ID: 2665271 [TBL] [Abstract][Full Text] [Related]
4. Cushing's disease in an 11-month-old child. Khadilkar VV; Khadilkar AV; Navrange JR Indian Pediatr; 2004 Mar; 41(3):274-6. PubMed ID: 15064517 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of pituitary Cushing's syndrome. Pituitary versus hypothalamic. Biller BM Endocrinol Metab Clin North Am; 1994 Sep; 23(3):547-54. PubMed ID: 7805653 [TBL] [Abstract][Full Text] [Related]
6. Cushing's disease. Therapy of pituitary adenomas. Tyrrell JB; Wilson CB Endocrinol Metab Clin North Am; 1994 Dec; 23(4):925-38. PubMed ID: 7705327 [TBL] [Abstract][Full Text] [Related]
8. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma. Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203 [TBL] [Abstract][Full Text] [Related]
10. Remission of pituitary-dependent Cushing's disease after removal of nonneoplastyic pituitary gland. Taylor HC; Velasco ME; Brodkey JS Arch Intern Med; 1980 Oct; 140(10):1366-8. PubMed ID: 6252859 [TBL] [Abstract][Full Text] [Related]
11. Nelson's syndrome after Cushing's disease in childhood: a continuing problem. Thomas CG; Smith AT; Benson M; Griffith J Surgery; 1984 Dec; 96(6):1067-77. PubMed ID: 6505960 [TBL] [Abstract][Full Text] [Related]
12. Surgical management of Cushing's syndrome. Bloom LS; Libertino JA Urol Clin North Am; 1989 Aug; 16(3):547-65. PubMed ID: 2665280 [TBL] [Abstract][Full Text] [Related]
13. Cushing's disease due to pituitary carcinoma. Zafar MS; Mellinger RC; Chason JL Henry Ford Hosp Med J; 1984; 32(1):61-6. PubMed ID: 6746304 [No Abstract] [Full Text] [Related]
14. Demonstration of pro-opiomelanocortin mRNA in pituitary adenomas and para-adenomatous gland in Cushing's disease and Nelson's syndrome. Fehn M; Farquharson MA; Sautner D; Saeger W; Lüdecke DK; McNicol AM J Pathol; 1993 Mar; 169(3):335-9. PubMed ID: 8492226 [TBL] [Abstract][Full Text] [Related]
15. CRH in Cushing's syndrome. Müller OA; Stalla GK; von Werder K Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289 [TBL] [Abstract][Full Text] [Related]
17. Mortality in Patients with Endogenous Cushing's Syndrome. Javanmard P; Duan D; Geer EB Endocrinol Metab Clin North Am; 2018 Jun; 47(2):313-333. PubMed ID: 29754634 [TBL] [Abstract][Full Text] [Related]
18. [Cushing's disease in a 12-month-old boy]. Youlton R Rev Chil Pediatr; 1981; 52(1):61-4. PubMed ID: 7255780 [No Abstract] [Full Text] [Related]
19. Use of bromocriptine for treatment of Cushing's disease caused by an adenoma originating from the intermediate lobe of the pituitary. Romer TE; Lastowiecki PM; Klimaszewski J Endokrynol Pol; 1987; 38(1):97-105. PubMed ID: 3428237 [No Abstract] [Full Text] [Related]
20. [Clinical case. Pituitary carcinoma with Cushing's syndrome and melanosis]. Rivadeneyra J; García-Alonso H; Pérez-Vega E; Aguilar-Parada E Arch Invest Med (Mex); 1971; 2(2):135-44. PubMed ID: 5136436 [No Abstract] [Full Text] [Related] [Next] [New Search]